Drug trial aims to tame lupus kidney attack
NCT ID NCT04883619
Summary
This study aimed to test if an investigational drug called nipocalimab could help control kidney damage in adults with active lupus nephritis. It was designed to work by lowering levels of harmful antibodies that attack the kidneys. The trial was a Phase 2 study that was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUPUS NEPHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.